NCT05939531

Brief Summary

The goal of this feasibility randomized controlled trial is to assess the feasibility and compare the changes in bone mineral density before and after the intervention in post-stroke older adults. The main question\[s\] it aims to answer are:

  • What are the baseline sociodemographic and bone health characteristics of post-stroke older adults in this study?
  • Is it feasible to undertake a larger RCT to assess the effectiveness and implementation of BOUNCE program?
  • Is there a difference in bone loss between groups?
  • Is there a difference in bone turnover markers at baseline and at six months?
  • Is there a difference in the incidence of falls and fragility fractures between groups?
  • How receptive are post-stroke patients/carers to the use of food/exercise diary?
  • What are the perceived motivators and barriers to implementation of BOUNCE program within real clinical settings among healthcare professionals, participants and carers?
  • What is the experience of healthcare professionals, participants and carers undergoing BOUNCE program? Participants will be divided into two groups:
  • Standard care
  • Intervention group (BOUNCE Program) Researchers will compare both groups to see any changes in the bone mineral density and bone turnover markers before and after the intervention.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Mar 2023

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2023

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

March 7, 2023

Completed
4 months until next milestone

First Posted

Study publicly available on registry

July 11, 2023

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2024

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2025

Completed
Last Updated

January 25, 2024

Status Verified

January 1, 2024

Enrollment Period

1.8 years

First QC Date

March 7, 2023

Last Update Submit

January 23, 2024

Conditions

Keywords

FeasibilityBone LossInterventionGeriatricsStroke

Outcome Measures

Primary Outcomes (1)

  • Change in Areal Bone Mineral Density (BMD) at the Neck of Femur as measured by Hologic Dual X-ray Absorptiometry in g/cm2

    To examine the difference in Areal BMD change pre and post-intervention between groups

    At baseline and month-6

Secondary Outcomes (8)

  • Recruitment uptake

    Throughout study period of average 1 year

  • Change in the level Bone Turnover Markers (BTM) as assessed by C-Telopeptide-Cross-Linked Type I Collagen (CTx) in ng/ml and Procollagen Type I N-Terminal Propeptide (PINP) in ng/ml

    At baseline and month-6

  • Retention

    Assessment at month-4 and month-6

  • Treatment adherence

    Assessment at month-4 and month-6

  • Acceptability

    Assessment at month-4 and month-6

  • +3 more secondary outcomes

Study Arms (2)

Standard Care

ACTIVE COMPARATOR

Standard post-stroke care

Behavioral: Standard Care

Intervention

EXPERIMENTAL

BOUNCE Program

Behavioral: BOUNCE Program

Interventions

BOUNCE ProgramBEHAVIORAL

Intervention arm: Bone-building exercises will be incorporated into the standard post-stroke exercises, as well as Nutritional intervention consisting of individualized diet plan based on calorie requirement, high-quality protein intake, vitamin D, Calcium and micronutrients with a one-to-one virtual session.

Intervention
Standard CareBEHAVIORAL

Standard post-stroke care

Standard Care

Eligibility Criteria

Age50 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 50 years old and older
  • Neurologist diagnosed acute stroke within 90 days
  • Has baseline biochemical test upon admission to the ward
  • Able to undergo DXA scan
  • Modified Rankin Score of 2 to 3
  • Able to walk with or without aids

You may not qualify if:

  • Known underlying malignancy
  • Known major depression or severe psychological illness
  • Known chronic kidney disease stage 3b (eGFR \<45ml/min/1.73m2) or more
  • Taken oral glucocorticoids therapy for at least three months
  • Presence of cognitive impairment (ECAQ \<7)
  • Presence of coronary artery syndrome or congestive cardiac failure
  • Presence of an uncontrolled respiratory condition
  • Underlying malabsorption syndrome
  • Underlying conditions other than stroke that impairs mobility (eg Severe Osteoarthritis, Parkinson's Disease, Multiple sclerosis)
  • Known osteoporosis or fragility fracture
  • Serum phosphate or calcium abnormalities
  • Discharge to a nursing home or rehabilitation centre
  • Already a participant in another trial/study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Sultan Abdul Aziz Shah

Serdang, Selangor, 43400, Malaysia

RECRUITING

MeSH Terms

Conditions

Bone Diseases, MetabolicStroke

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Bone DiseasesMusculoskeletal DiseasesMetabolic DiseasesNutritional and Metabolic DiseasesCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Sazlina Shariff-Ghazali, PhD

    Universiti Putra Malaysia

    STUDY CHAIR

Central Study Contacts

Hakimah Mohammad Sallehuddin, MBBS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 7, 2023

First Posted

July 11, 2023

Study Start

March 1, 2023

Primary Completion

November 30, 2024

Study Completion

August 31, 2025

Last Updated

January 25, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will not share

Locations